Engels

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 Formulieren  
General information
Beschrijving

General information

Protocol indentifier
Beschrijving

Protocol indentifier

Datatype

text

Subject Identifier
Beschrijving

Subject Identifier

Datatype

text

Alias
UMLS CUI [1]
C2348585
Visit date
Beschrijving

Visit date

Datatype

date

Visit Description
Beschrijving

Visit Description

Datatype

text

Concomitant medication
Beschrijving

Concomitant medication

Concomitant medication
Beschrijving

Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.

Datatype

text

L-Dopa medication changes
Beschrijving

L-Dopa medication changes

Has there been any change in dose or frequency of L-Dopa medication since the last visit?
Beschrijving

Note: Record any changes to the subject's L-Oopa medication taken since the last visit in the L-Dopa Medication section and contact GSK

Datatype

boolean

Parkinson's Disease Symptom Control
Beschrijving

Parkinson's Disease Symptom Control

Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
Beschrijving

Parkinson's Disease Symptom Control

Datatype

boolean

Terug naar het begin van de pagina

Similar models

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
General information
Protocol indentifier
Item
Protocol indentifier
text
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit date
Item
Visit date
date
Visit Description
Item
Visit Description
text
Item Group
Concomitant medication
Concomitant medication
Item
Concomitant medication
text
Item Group
L-Dopa medication changes
change of L-Dopa medication
Item
Has there been any change in dose or frequency of L-Dopa medication since the last visit?
boolean
Item Group
Parkinson's Disease Symptom Control
Parkinson's Disease Symptom Control
Item
Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
boolean
Terug naar het begin van de pagina